|Ticker||Company name||Industry||Market Cap
|Dividend Yield||Dividend Frequency||Stock price||Currency||Stock Exchange|
|DSM||Koninklijke DSM NV||Basic Materials||23.11||1.79 %||Semi-Annual||134||EUR||Euronext Amsterdam|
Company's Past Performance
The 5 years average P/E ratio is the average of each year’s P/E ratios. P/E ratio in any year is limited to 30 in order to reduce the effect of the extreme values on the average P/E.
Royal DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company operates through the following segments: Nutrition, Performance Materials, Pharma, Polymer Intermediates, Innovation Center, and Corporate Activities. The Nutrition segment comprises of the DSM Nutritional Products and DSM Food Specialties business groups, which concentrate on human nutrition and animal nutrition health. The Pharma segment develops and manufactures pharmaceutical products. The Performance Materials segment produces synthetic fibers, engineering plastics, and resins used in coatings, and include DSM Engineering Plastics, DSM Dyneema, and DSM Resins. The Innovation Center segment enables and accelerates of innovation, which includes Emerging Business Areas (EBAs). The Polymer Intermediates segment consists of DSM Fibre Intermediates. The Corporate Activities segments involves operating and service activities. The company was founded in 1902 and is headquartered in Herleen, the Netherlands.